Literature DB >> 15574368

Polyoxometalates: introduction to a class of inorganic compounds and their biomedical applications.

Bernold Hasenknopf1.   

Abstract

An increasing number of potential applications for polyoxometalates in human medicine have been reported in the literature. These inorganic complexes are composed of early transition metals (mainly molybdenum, tungsten and vanadium) and oxygen. The present review gives an introduction into the chemistry of these compounds, and an overview of the principal studies of their biological and biochemical effects and their therapeutic potential. The reported antitumoral and antibiotic properties of molybdates and tungstates in vitro and in vivo are compiled and discussed, as are their influences on the blood glucose level in diabetic animals. Aspects of antiviral activities and cell penetration are treated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15574368     DOI: 10.2741/1527

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  39 in total

1.  Polyoxometalates functionalized by bisphosphonate ligands: synthesis, structural, magnetic, and spectroscopic characterizations and activity on tumor cell lines.

Authors:  Hani El Moll; Wei Zhu; Eric Oldfield; L Marleny Rodriguez-Albelo; Pierre Mialane; Jérôme Marrot; Neus Vila; Israel Martyr Mbomekallé; Eric Rivière; Carole Duboc; Anne Dolbecq
Journal:  Inorg Chem       Date:  2012-06-22       Impact factor: 5.165

2.  CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma.

Authors:  Gregory M Hayes; Belinda Cairns; Zoia Levashova; Lawrence Chinn; Myra Perez; Jan-Willem Theunissen; Sindy Liao-Chan; Abel Bermudez; Mark R Flory; Karl J Schweighofer; Edward H van der Horst
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

3.  Anticancer Activity of Polyoxometalate-Bisphosphonate Complexes: Synthesis, Characterization, In Vitro and In Vivo Results.

Authors:  Amandine Boulmier; Xinxin Feng; Olivier Oms; Pierre Mialane; Eric Rivière; Christopher J Shin; Jiaqi Yao; Tadahiko Kubo; Taisuke Furuta; Eric Oldfield; Anne Dolbecq
Journal:  Inorg Chem       Date:  2017-06-20       Impact factor: 5.165

4.  CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice.

Authors:  Xiaofeng Sun; Yan Wu; Wenda Gao; Keiichi Enjyoji; Eva Csizmadia; Christa E Müller; Takashi Murakami; Simon C Robson
Journal:  Gastroenterology       Date:  2010-06-25       Impact factor: 22.682

5.  Tetra- to dodecanuclear oxomolybdate complexes with functionalized bisphosphonate ligands: activity in killing tumor cells.

Authors:  Jean-Daniel Compain; Pierre Mialane; Jérôme Marrot; Francis Sécheresse; Wei Zhu; Eric Oldfield; Anne Dolbecq
Journal:  Chemistry       Date:  2010-12-10       Impact factor: 5.236

6.  Controlled drug delivery and cell adhesion for bone tissue regeneration by Keplerate polyoxometalate (Mo132)/metronidazole/PMMA scaffolds.

Authors:  Hamid Taghiyar; Bahram Yadollahi; Abolghasem Abbasi Kajani
Journal:  Sci Rep       Date:  2022-08-24       Impact factor: 4.996

Review 7.  Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) and its inhibitors.

Authors:  Sang-Yong Lee; Christa E Müller
Journal:  Medchemcomm       Date:  2017-02-09       Impact factor: 3.597

8.  Bis-[4,4'-(propane-1,3-di-yl)-dipiperidin-ium] β-octa-molybdate(VI).

Authors:  Mohamed Driss; Rekaya Ksiksi; Fatma Ben Amor; Mohamed Faouzi Zid
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-04-17

9.  Label-free colorimetric detection of mercury via Hg(2+) ions-accelerated structural transformation of nanoscale metal-oxo clusters.

Authors:  Kun Chen; Shan She; Jiangwei Zhang; Aruuhan Bayaguud; Yongge Wei
Journal:  Sci Rep       Date:  2015-11-12       Impact factor: 4.379

10.  Fine-tuning the antimicrobial profile of biocompatible gold nanoparticles by sequential surface functionalization using polyoxometalates and lysine.

Authors:  Hemant K Daima; P R Selvakannan; Ravi Shukla; Suresh K Bhargava; Vipul Bansal
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.